IAG:NYSEIamgold Corporation Analysis
Data as of 2026-04-09 - not real-time
$19.67
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
IAMGOLD is trading at $19.67, comfortably above its 200‑day SMA (≈$14.06) and the 20‑day SMA (≈$18.61) but below the 50‑day SMA (≈$20.33), placing it in a neutral technical zone with a bullish MACD histogram (+0.27) and a moderate RSI (52). Volatility is high at 64.6% over the past 30 days, yet the stock’s beta of 0.37 indicates limited correlation with broader market moves, tempering systematic risk. The company boasts exceptionally high operating margins (≈52%) and a solid profit margin (≈23%), supported by a low debt‑to‑equity profile (≈18%) and ample cash reserves. DCF analysis suggests a fair value of $33.13, implying roughly a 39% upside from current levels, while forward earnings multiple contracts at 8.8×, reinforcing the undervaluation case. Analyst consensus is a “Buy” with a mean target of $27.3, and recent news highlights a streak of earnings‑beat reports and a perceived turnaround narrative, fueling investor enthusiasm. Despite the lack of a dividend, the strong cash flow generation and low leverage make the balance sheet resilient. Overall, the blend of attractive valuation, robust profitability, and positive sentiment positions IAMGOLD as a compelling opportunity, though the high short‑term price swing potential warrants careful timing.
Given the commodity‑driven nature of gold mining, sector‑specific risks remain, but the company’s diversified geography (Canada and Burkina Faso) and solid fundamentals provide a sturdy foundation for medium‑ to long‑term upside.
Given the commodity‑driven nature of gold mining, sector‑specific risks remain, but the company’s diversified geography (Canada and Burkina Faso) and solid fundamentals provide a sturdy foundation for medium‑ to long‑term upside.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram despite neutral price positioning
- Significant upside potential from DCF fair value
- Recent earnings beats reinforcing momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong operating and profit margins
- Low leverage and solid cash flow generation
- Analyst consensus and target price indicating upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervaluation relative to intrinsic DCF estimate
- Sustainable growth prospects in gold production
- Resilient balance sheet with low debt and ample liquidity
Key Metrics & Analysis
Financial Health
Revenue Growth131.60%
Profit Margin23.29%
P/E Ratio17.3
ROE19.15%
ROA12.29%
Debt/Equity17.94
P/B Ratio2.8
Op. Cash Flow$1.1B
Free Cash Flow$538.0M
Technical Analysis
TrendNeutral
RSI52.4
Support$15.78
Resistance$21.93
MA 20$18.61
MA 50$20.33
MA 200$14.06
MACDBullish
VolumeDecreasing
Fear & Greed Index83.41
Valuation
Fair Value$33.13
Target Price$27.30
Upside/Downside38.79%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.37
Volatility64.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.